Resources from the same session
2064 - Phase III trial of Lurbinectedin versus PLD or Topotecan in platinum-resistant ovarian cancer patients: Results of CORAIL trial
Presenter: Stephanie Gaillard
Session: Proffered paper session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
2361 - Carboplatin/pegylated liposomal Doxorubicin/Bevacizumab (CD-BEV) vs. Carboplatin/Gemcitabine/Bevacizumab (CG-BEV) in patients with recurrent ovarian cancer. A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO Study Group, AGO-Austria, ANZGOG, GINECO, SGCTG).
Presenter: Jacobus Pfisterer
Session: Proffered paper session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
3404 - Alienor/ENGOT-ov7 randomized trial exploring weekly Paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian Sex Cord tumors (SCT) in relapse
Presenter: Isabelle Ray-Coquard
Session: Proffered paper session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
1946 - OVPSYCH2: A randomised study of psychological support versus standard of care following chemotherapy for ovarian cancer
Presenter: Sarah Blagden
Session: Proffered paper session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered paper session - Gynaecological cancers - Invited Discussant 933O and 934O
Presenter: Susana Banerjee
Session: Proffered paper session - Gynaecological cancers
Resources:
Slides
Webcast